TMPRSS2 and cancer: When we consider the risk–benefit in the expression profiles of SARS-CoV-2 entry proteins, we believe that groups of women, with expression of ACE2 and TMPRSS2 proteins in their endometria during the period of pandemic, might be safe as well even a small proportion of these women contain some malignant tumors.